Aurobindo receives FDA nod for diclofenac sodium topical solution
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application diclofenac sodium topical solution USP, 2% w/w.